Intuitive Surgical, Inc. (NASDAQ:ISRG) Position Increased by Advisory Services Network LLC

Advisory Services Network LLC raised its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 13.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 24,986 shares of the medical equipment provider’s stock after purchasing an additional 2,886 shares during the quarter. Advisory Services Network LLC’s holdings in Intuitive Surgical were worth $13,042,000 at the end of the most recent quarter.

Other hedge funds also recently bought and sold shares of the company. M.E. Allison & CO. Inc. bought a new stake in Intuitive Surgical in the fourth quarter worth $449,000. Seilern Investment Management Ltd bought a new position in shares of Intuitive Surgical in the fourth quarter worth about $82,517,000. Sycomore Asset Management lifted its position in shares of Intuitive Surgical by 27.4% during the 4th quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider’s stock worth $9,214,000 after purchasing an additional 4,079 shares during the last quarter. Exome Asset Management LLC lifted its holdings in shares of Intuitive Surgical by 16.8% during the third quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock worth $3,649,000 after buying an additional 1,069 shares during the last quarter. Finally, China Universal Asset Management Co. Ltd. raised its stake in Intuitive Surgical by 5.6% during the 4th quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider’s stock valued at $5,138,000 after purchasing an additional 525 shares during the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In related news, VP Fredrik Widman sold 810 shares of the business’s stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $573.78, for a total value of $464,761.80. Following the sale, the vice president now directly owns 473 shares of the company’s stock, valued at approximately $271,397.94. The trade was a 63.13 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CFO Jamie Samath sold 94 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total transaction of $53,684.34. Following the completion of the sale, the chief financial officer now owns 2,630 shares in the company, valued at $1,502,019.30. This trade represents a 3.45 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 33,754 shares of company stock worth $17,691,621 in the last 90 days. Corporate insiders own 0.70% of the company’s stock.

Intuitive Surgical Trading Up 2.7 %

Shares of Intuitive Surgical stock opened at $463.62 on Tuesday. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00. The stock’s fifty day simple moving average is $542.98 and its 200 day simple moving average is $532.81. The company has a market capitalization of $165.13 billion, a PE ratio of 72.33, a PEG ratio of 5.85 and a beta of 1.55.

Wall Street Analyst Weigh In

A number of research analysts have commented on the stock. Bernstein Bank raised their price target on shares of Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a research note on Monday, January 27th. Piper Sandler reiterated an “overweight” rating and set a $670.00 price objective (up from $538.00) on shares of Intuitive Surgical in a research note on Friday, January 24th. Evercore ISI boosted their target price on shares of Intuitive Surgical from $490.00 to $530.00 in a research note on Monday, January 27th. Barclays increased their target price on shares of Intuitive Surgical from $610.00 to $674.00 in a research report on Monday, January 27th. Finally, Truist Financial reduced their price target on shares of Intuitive Surgical from $666.00 to $605.00 and set a “buy” rating on the stock in a research report on Monday, March 17th. One analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $611.86.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.